Sevelamer
Renagel (sevelamer) is a small molecule pharmaceutical. Sevelamer was first approved as Renagel on 1998-10-30. It is used to treat hyperphosphatemia in the USA. It has been approved in Europe to treat hyperphosphatemia and renal dialysis.
| Trade Name | Renagel |
|---|---|
| Common Name | Sevelamer |
| Indication | hyperphosphatemia, renal dialysis |
| Drug Class | Polymers |
